Overview

Adjunctive Clindamycin for Cellulitis: C4C Trial.

Status:
Unknown status

Trial end date:
2016-01-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to see whether the addition of Clindamycin, a protein inhibiting antibiotic, to the standard antibiotic treatment of limb cellulitis, with Flucloxacillin, results in less tissue damage and a more rapid resolution of both systemic and local features, in a cost-effective manner. This study is a randomised controlled trial comparing Clindamycin with placebo.

Phase:

Phase 4

Details

Lead Sponsor:

University Hospitals Bristol and Weston NHS Foundation Trust
University Hospitals Bristol NHS Foundation Trust

Collaborators:

Public Health England
University of Bristol

Treatments:

Clindamycin
Clindamycin palmitate
Clindamycin phosphate
Floxacillin